Nuwellis (NUWE) Share-based Compensation Growth (3y) (2014 - 2026)
Powered by 
Analysis
Nuwellis (NUWE) Share-based Compensation Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 8.37% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -22.92% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 19.64% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -28.31% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 0.55% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 4.11% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 7.30% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -0.59% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.40% |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | -51.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.84% |
| Mar 31, 2026 | -42.48% |
| Dec 31, 2025 | -47.41% |
| Sep 30, 2025 | -55.80% |
| Jun 30, 2025 | -58.39% |
| Mar 31, 2025 | -34.73% |
| Dec 31, 2024 | -31.32% |
| Sep 30, 2024 | -26.75% |
| Jun 30, 2024 | -32.92% |
| Mar 31, 2024 | -23.65% |
| Dec 31, 2023 | -20.55% |
| Sep 30, 2023 | -24.20% |
| Jun 30, 2023 | -17.20% |
| Mar 31, 2023 | -21.90% |
| Dec 31, 2022 | -25.50% |
| Sep 30, 2022 | -18.87% |
| Jun 30, 2022 | -11.37% |
| Mar 31, 2022 | -12.68% |
| Dec 31, 2021 | -16.07% |
| Sep 30, 2021 | -16.22% |